Jubilant Pharmova Ltd.
JUBLPHARMAHealthcareR1 raw held document library
Coverage
| Dataset | On disk | Usable | State |
|---|---|---|---|
| Results XBRL (NSE + BSE) | 99 | 32 | 32 quarter-ends |
| Annual reports | 11 | 11 | identity graded |
| Earnings calls | 7 | 4 | transcripts and analyst meets only |
| Shareholding | 20 | 20 | |
| Related party | 5 | 5 | |
| Investor decks | 0 | 0 | cohort of 48 companies only |
Financial statements in parse — expected 19 Sep 2026. Nothing from the superseded legacy store is shown.
Earnings calls
6 transcript(s)/analyst meet(s) served; 3 document(s) on file are not transcripts (cover letters, duplicates, unresolved) and are excluded. Speaker attribution is shown only where the segmenter attributes ≥ 95% of sentences to management or analysts (0 of 6 documents here); elsewhere sentences render unattributed.
| Kind | Date | Period | Served | Attribution rate |
|---|---|---|---|---|
| COVER_LETTER | 20220528 | 2022-03-31 | no | |
| TRANSCRIPT | 20220602 | 2022-03-31 | yes | |
| COVER_LETTER | 20220802 | 2022-06-30 | no | |
| TRANSCRIPT | 20220808 | 2022-06-30 | yes | |
| COVER_LETTER | 20230203 | 2022-12-31 | no | |
| TRANSCRIPT | 20230209 | 2022-12-31 | yes | |
| TRANSCRIPT | 20260527 | 2026-03-31 | yes |